explore -WSS

explore

author：comprehensive 2025-09-29 01:38:16 - browse：6594

Since the early days of the pandemic, long Covid has haunted us: Even a mild acute infection might leave you with life-altering consequences. And for many, that has, sadly, turned out to be the case. While research suggests long Covid rates are falling, it still affects millions. In June 2023, 6% of Americans reported experiencing long Covid.

But what if long Covid isn’t the right way to think about what they are going through?

On this episode of the First Opinion Podcast, I spoke with Steven Phillips and Michelle A. Williams, authors of a recent First Opinion essay titled, “Long Covid is a new name for an old syndrome.” Steven is a Global Virus Network board member and vice president for science and strategy at the COVID Collaborative; Michelle is the former dean and current Joan and Julius Jacobson professor of epidemiology and public health at the Harvard T.H. Chan School of Public Health.

“Michelle and I have come up with basically a new paradigm that says long Covid is really an old disease, and the more you do deep dives into the history of chronic fatigue syndrome and post-infectious fatigue syndromes, the more you realize that not only are there similarities, but the level of congruence between the two is strikingly high,” Steven said.

The purpose of this new paradigm is to “break the logjam” of the current long Covid discourse and “to try to provide a framework whereby people would think about long Covid in a different way in a way that would be more productive,” Michelle told me.

We discussed the history of post-infectious disease syndrome, what rethinking long Covid might mean for research, and the ways the health care system fails chronically ill patients.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Patients, digital health players weigh in on FTC's data privacy plan

leisure time

explore

WSS

Idaho college killings prosecutors challenge defense's grand jury claims

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

CDC marks new Covid

Biogen’s boardroom scandal saddles CEO with first crisis

Change Healthcare payments predicted restored March 15

Illumina slashes 2023 revenue projections yet again

focus

explore

knowledge

Jerome Adams on the need for new antivirals for Covid

Headspace, Meta partner to launch VR meditation app for Quest

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Change Healthcare payments predicted restored March 15

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The drug industry has found itself all alone in Washington

Apple is now the first public company to be valued at $3 trillion

Senators push IRS to launch nonprofit hospital probe

Duchenne breakthrough therapy leaves behind pioneering families

How to bring more disabled researchers into academia

focus

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

RSV shot was 90% effective at preventing hospitalizations in kids

BMS, looking to build heart drug business, turns to AI for diagnosis

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Biden administration begins canceling student loan debt for 804,000 borrowers

Schizophrenia gene found to be linked to cells' energy dysfunction

leisure time

focus

explore

focus